Clinical trials · Pennsylvania
Classic Congenital Adrenal Hyperplasia clinical trials in Pennsylvania
We’re tracking 3 recruiting classic congenital adrenal hyperplasia studies with a site in Pennsylvania — including Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Pennsylvania
- NCT07159841RecruitingPhase 2/Phase 3
Study of a new drug for children with classic CAH
This study tests a new medication for children with classic congenital adrenal hyperplasia (CAH). It aims to see if the drug helps better control hormone levels and reduce the need for high doses of current steroid medicines.
Philadelphia, PennsylvaniaAges 1–17 - NCT07144163RecruitingPhase 3
Atumelnant for adults with classic CAH
This study tests a new drug, atumelnant, for adults with classic congenital adrenal hyperplasia (CAH) caused by 21-OHD. It aims to see if it can help control hormone levels while allowing lower doses of current steroid medications.
Philadelphia, PennsylvaniaAges 18–74 - NCT06712823RecruitingPhase 2
Long-term safety study of atumelnant for adrenal hyperplasia
This study tests the long-term safety and effectiveness of the study drug atumelnant for people with congenital adrenal hyperplasia. It is for those who have already completed a previous atumelnant study and may benefit from continuing treatment.
Philadelphia, PennsylvaniaAges 16–74
Where these studies are running in Pennsylvania
Institutions with a site for the recruiting classic congenital adrenal hyperplasia studies listed above.
- Investigative Site · 2 studies
- Children's Hospital of Philadelphia
- Crinetics Study Site
What taking part in a classic congenital adrenal hyperplasia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Classic Congenital Adrenal Hyperplasia trials in other states
Common questions
- Are there classic congenital adrenal hyperplasia clinical trials in Pennsylvania?
- Yes. We're currently tracking 3 recruiting classic congenital adrenal hyperplasia studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a classic congenital adrenal hyperplasia study in Pennsylvania?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Pennsylvania to take part?
- Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a classic congenital adrenal hyperplasia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New classic congenital adrenal hyperplasia studies open in Pennsylvania regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.